WO2024127361 - ENZALUTAMIDE NANOCRYSTALS, METHODS AND COMPOSITIONS
National phase entry is expected:
Publication Number
WO/2024/127361
Publication Date
20.06.2024
International Application No.
PCT/IB2023/062806
International Filing Date
15.12.2023
Title **
[English]
ENZALUTAMIDE NANOCRYSTALS, METHODS AND COMPOSITIONS
[French]
NANOCRISTAUX D'ENZALUTAMIDE, MÉTHODES ET COMPOSITIONS
Applicants **
FERRING B.V.
Inventors
CARVALHO, Flavia Chiva
BONI, Fernanda Isadora
ZARDI, Denise
FARO, Renato
BIZ, Gabriela
TUNDISI, Louise L.
Priority Data
63/433,168
16.12.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3576 | |
| EPO | Filing, Examination, Granting | 44403 | |
| Japan | Filing, Examination, Granting | 3712 | |
| South Korea | Filing, Examination, Granting | 5048 | |
| USA | Filing, Examination, Granting | 17740 |
Total:
74,479
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Described herein are processes for preparing enzalutamide nanocrystals, compositions and pharmaceutical compositions comprising them, and therapeutic methods using them.[French]
La présente invention concerne des procédés de préparation de nanocristaux d'enzalutamide, des compositions et des compositions pharmaceutiques les contenant, et des méthodes thérapeutiques les utilisant.